Aquarius Surgical Technologies Closes First Tranche of Private Placement
TORONTO, ON / ACCESSWIRE / June 27, 2019 / Aquarius Surgical Technologies Inc. (CSE: ASTI) ("Aquarius" or "the Company") today...
user
Theralase Files Prospectus for Offering of Units
Not for Distribution to United States Newswire Services or for Dissemination in the United States TORONTO, ON / ACCESSWIRE /...
Nursing & Midwifery Council to use Rizikon Assurance from Crossword Cybersecurity PLC to Automate Supplier Onboarding and Improve Supplier Risk Management
27th June 2019 – London, UK – Crossword Cybersecurity plc (AIM: CCS) has today announced that the Nursing and Midwifery...
Eggplant and iMethods Expand Relationship
iMethods attains Eggplant Endorsed Service Provider statusBoulder, CO, June 26, 2019: Eggplant the intelligent test automation specialist, today announced iMethods,...
Jaguar Health Engages Integrium, LLC to Support Clinical Study Evaluating the Effect of Mytesi on the Microbiome
Study will Examine the Possible Benefits of Mytesi® on Gut Health, Including Bloating and Abdominal Discomfort, in People Living with...
StageZero Life Sciences Ltd Announces Initiation Of Trading Under The Stock Trading Symbol SZLS
TORONTO, ON / ACCESSWIRE / June 26, 2019 / StageZero Life Sciences Ltd (Formerly GeneNews or the "Company") (TSX: GEN)...
Health Canada Approves Amended Clinical Trial Application
TORONTO, ON / ACCESSWIRE / June 26, 2019 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV: TLT) (OTCQB: TLTFF), a...
EyeGate Announces First Patient Enrolled in PRK Pivotal Study
WALTHAM, MA / ACCESSWIRE / June 26, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today...
Evotec Se Places First Schuldschein (Promissory Note) Worth Eur 250 M
PROCEEDS TO BE USED FOR GENERAL CORPORATE FINANCING INCLUDING FINANCING OF JUST.BIO ACQUISITION, EXPANSION, AND REFINANCING STRONG PERFORMANCE AND OUTLOOK...
Pharnext Announces the Apppointment of Peter Collum as Chief Financial Officer and Chief Business Officer
PARIS, FRANCE / ACCESSWIRE / June 26, 2019 / Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new...
VistaGen Therapeutics Reports Fiscal Year 2019 Results and Provides CNS Pipeline Overview
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / June 25, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Dr. Jeffrey Morgan Discusses the Reality of Bioprinted Hearts for Patients With Advanced Heart Failure
Dr. Jeffrey A. Morgan is Cardiac Surgeon Specializing in the Treatment of Advanced Heart Failure with Mechanical Assist Devices and...
Premark Pharma Licenses Worldwide Rights to PMP2207 for Ophthalmic Indications and Targets a First Regulatory Approval for Blepharitis
BASEL, SWITZERLAND / ACCESSWIRE / June 25, 2019 / Premark Pharma announced today the completion of a licensing deal with...
International Cannabrands Announces La Vida Verde Signs Sales Expansion Agreement with the Bettie Janes and Receives Annual Distribution License
DENVER, CO / ACCESSWIRE / June 25, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
DECN in Pact with Mega Pet Products Retailer Fetch for Pets Tripling Market For Company’s Petsure Test Strips and Genultimate! 4pets Test Strips and Meters
LOS ANGELES, CA / ACCESSWIRE / June 25, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year...
EastWest Bioscience Starts Production of CBD Pet Treats for the US Market
VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that, further...
Viveve Announces FDA 510(k) Clearance of Viveve 2.0 Next Generation System in the U.S.
Company also announces expansion of distribution network targeting gynecology practices in the Middle East through partnership with Dansys Group ENGLEWOOD,...
Aytu BioScience Announces First Clinical Results Demonstrating Clinical Utility of MiOXSYS Male Infertility Test When Used Prior to In Vitro Fertilization (IVF) Procedures
First Clinical Data Demonstrating Predictive Power of Seminal Oxidation-Reduction Potential (ORP) as a Predictor of Fertilization When Used Prior to...
Theralase Brain Cancer Pre-Clinical Research Accepted for Publication
Research Detailing Advantages of Rutherrin® PhotoDynamic Therapy in deadly brain cancer, GlioBlastoma Multiforme ("GBM") to be Published in the Journal...
CORRECTION: Ad hoc: MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer
Correction of a release disseminated on June 24, 2019. Correction of an inside information acc. to Article 17 MAR of...